Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GABRB1 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit beta-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRA5 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit alpha-5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRA5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRA4 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit alpha-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRA4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRA3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit alpha-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABBR2 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid type B receptor subunit 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABBR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRA1 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit alpha-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRA2 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit alpha-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FPR1 Biologics Sequence Review Report 2026: N-formyl peptide receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FPR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FPR3 Biologics Sequence Review Report 2026: N-formyl peptide receptor 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FPR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FSHR Biologics Sequence Review Report 2026: Follicle-stimulating hormone receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FSHR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FPR2 Biologics Sequence Review Report 2026: N-formyl peptide receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
EDNRB Biologics Sequence Review Report 2026: Endothelin receptor type B Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of EDNRB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
247
248
249
250
251
>>
1905
>